Ratio Examination: Checkpoint Therapeutics Inc (CKPT)’s Price-to-Cash and Price-to-Free Cash Flow

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Checkpoint Therapeutics Inc (NASDAQ: CKPT) closed at $3.16 down -0.63% from its previous closing price of $3.18. In other words, the price has decreased by -$0.63 from its previous closing price. On the day, 0.93 million shares were traded. CKPT stock price reached its highest trading level at $3.288 during the session, while it also had its lowest trading level at $3.08.

Ratios:

For a deeper understanding of Checkpoint Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.26 and its Current Ratio is at 0.26.

On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.

On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 26 ’24 when Oliviero James F III sold 24,610 shares for $2.05 per share. The transaction valued at 50,450 led to the insider holds 1,977,170 shares of the business.

GRAY WILLIAM GARRETT sold 13,038 shares of CKPT for $26,858 on Jun 26 ’24. The Chief Financial Officer now owns 672,186 shares after completing the transaction at $2.06 per share. On Feb 28 ’24, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 5,894 shares for $2.06 each. As a result, the insider received 12,142 and left with 350,836 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 142256256 and an Enterprise Value of 137305376. For the stock, the TTM Price-to-Sale (P/S) ratio is 1778.29. Its current Enterprise Value per Revenue stands at 1760.325.

Stock Price History:

Over the past 52 weeks, CKPT has reached a high of $3.62, while it has fallen to a 52-week low of $1.36. The 50-Day Moving Average of the stock is 33.89%, while the 200-Day Moving Average is calculated to be 52.90%.

Shares Statistics:

For the past three months, CKPT has traded an average of 433.19K shares per day and 680720 over the past ten days. A total of 45.02M shares are outstanding, with a floating share count of 37.36M. Insiders hold about 17.01% of the company’s shares, while institutions hold 13.21% stake in the company. Shares short for CKPT as of 1727654400 were 4375843 with a Short Ratio of 10.10, compared to 1724976000 on 4094310. Therefore, it implies a Short% of Shares Outstanding of 4375843 and a Short% of Float of 10.520000999999999.

Most Popular